This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Procrit

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Procrit Means in Everyday Medical Language

Procrit is a medicine designed to help the body produce more red blood cells. Red blood cells carry oxygen to the body’s tissues, and when their numbers are low, a condition called anemia occurs. Anemia can cause symptoms like feeling tired, weak, or short of breath. Procrit is a lab-made version of erythropoietin, a hormone normally made by the kidneys that signals the bone marrow to make red blood cells. When the kidneys don’t produce enough erythropoietin or when chemotherapy lowers red blood cell counts, Procrit can help fill this gap.

Why Procrit Can Matter in Cancer Care

Many people with cancer develop anemia, especially if they are receiving chemotherapy, which can reduce red blood cell production. Anemia can affect quality of life and make it harder to tolerate cancer treatments. Procrit is used to treat anemia caused by chemotherapy or chronic kidney disease, helping to raise red blood cell levels. This can improve energy and reduce the need for blood transfusions. While Procrit is not a cancer treatment itself, it supports patients by managing a common side effect of cancer therapy.

What Patients Might See or Hear About Procrit

You might see the names Procrit, Epogen, or Retacrit on your medication list, treatment plan, or lab reports. Your healthcare team may mention Procrit when discussing anemia or options to manage side effects of chemotherapy. Seeing the name does not always mean you will receive this medicine or that your anemia is severe; it simply indicates that this treatment is available if needed. It’s important to ask your care team how Procrit fits into your specific care plan.

How Doctors Use Procrit During Cancer Treatment

Doctors may recommend Procrit after blood tests show low red blood cell counts. The decision to use it depends on your overall health, type of cancer, chemotherapy schedule, and anemia severity. Procrit is given as an injection and is part of a broader approach to support your health during treatment. It is used carefully because it carries some risks, so doctors aim to use the lowest dose needed to avoid blood transfusions.

Safety and Important Risks

Procrit is generally well tolerated but can cause side effects such as high blood pressure, headache, joint pain, and clotting at the injection site. Rare but serious risks include blood clots, heart attack, stroke, and allergic reactions. Because of these risks, doctors carefully weigh the benefits and monitor patients closely. It is important to follow your healthcare team’s advice and report any new symptoms promptly.

How Procrit Connects to Related Terms

Procrit is a brand name for epoetin alfa, which is part of a group of medicines called erythropoiesis-stimulating agents (ESAs). These drugs work by encouraging the bone marrow to make more red blood cells. Other brand names for epoetin alfa include Epogen and Retacrit. Another related drug is darbepoetin alfa (brand name Aranesp), which works similarly but has a different structure.

How to Read the Term in Context and Next Steps

Procrit may appear under different brand names or in medical records, so comparing the wording can help avoid confusion. This information is educational and does not replace personalized medical advice. If you see Procrit mentioned in your records or hear about it during visits, the best next step is to talk openly with your healthcare team about what it means for your care, how it might help you, and what side effects to watch for.

Sources

Public source information used for this glossary entry includes: